Skip to main content
. 2021 Aug 17;62(9):806–813. doi: 10.3349/ymj.2021.62.9.806

Table 3. Stratified Risk Group by Score and Mortality in the Development and Validation Groups.

Score Risk group Development group Validation group
Number of patients (%) Number of deaths (%) Number of patients (%) Number of deaths (%)
0–3 Low 682 (55.4) 9 (0.6) 298 (56.4) 1 (0.3)
4–6 Intermediate 248 (20.1) 20 (18.4) 110 (20.8) 6 (5.5)
7–10 High 168 (13.6) 44 (19.4) 65 (12.3) 15 (23.1)
≥11 Very high 134 (10.9) 106 (50.0) 55 (10.4) 23 (41.8)
Overall 1232 179 528 45